THE MEDICAL NEWS

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and causes organs to fail. Africa bears the world's highest burden of sepsis, with an estimated 48 million cases each year leading to about 11 million deaths.

Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48 hours of stroke symptoms, had better recovery than patients who received a placebo, according to a preliminary late-breaking science presentation at the American Stroke Association's International Stroke Conference 2026.

Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the disease spreads throughout the abdomen.

A new study from National Jewish Health helps explain how exposure to burn pit smoke and desert dust may damage the lungs of military service members deployed to regions such as Afghanistan and Iraq.

In infants and toddlers who had a stroke before birth or as a newborn (28 days or younger), a treatment that combined restricting the use of the stronger arm with intensive task-oriented physical therapy led to improved function and skill gained on the weak side compared to standard care, according to preliminary late-breaking science presented today at the American Stroke Association's Internati…

Antibiotic resistance (AR) has steadily accelerated in recent years to become a global health crisis. As deadly bacteria evolve new ways to elude drug treatments for a variety of illnesses, a growing number of "superbugs" have emerged, ramping up estimates of more than 10 million worldwide deaths per year by 2050.

For the millions of people living with end‑stage kidney disease, hemodialysis is more than a medical procedure, it is a thrice‑weekly lifeline that keeps the body's chemistry in balance.

New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may significantly reduce the risk of atrial fibrillation (AF) returning, offering patients a simple, low-cost way to support long-term heart health.

Rice University bioengineer Antonios Mikos is part of a team of researchers led by the Wake Forest Institute for Regenerative Medicine awarded up to $24.8 million over five years to help address the nation's growing organ donor shortage by bioprinting on-demand kidney tissues.